Passive immunization against tumour necrosis factor-alpha (TNF-α) and IL-lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats
Open Access
- 1 November 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 90 (2) , 312-318
- https://doi.org/10.1111/j.1365-2249.1992.tb07948.x
Abstract
Glomerular injury caused by injection of heterologous anti-glomerular basement membrane antibodies (anti-GBM Ab) is increased in rats pretreated with small doses of bacterial lipopolysaccharide (LPS). We have investigated the involvement of tumour necrosis factor-alpha (TNF-α), IL-lα and IL-1 β in this phenomenon by passive immunization against these cytokines. Anti-TNF-α or anti-IL-1β antibodies given 1–5 h before the induction of nephritis significantly decreased injury in this model, whether assessed by the magnitude of albuminuria, the prevalence of glomerular capillary thrombi or the intensity of glomerular neutrophil infiltrate. Albuminuria in anti-GBM Ab alone was 11 ± 3, LPS/anti-GBM Ab 87±22, and anti-TNF-α antibodies/LPS/anti-GBM Ab 21 ±6 mg/24 h (mean ± s.e.) P< 0.05. Passive immunization with antibodies to IL-1 β had a similar effect (anti-GBM Ab, 0.6±01, LPS/anti-GBM Ab, 92±19, anti-IL-1β antibodies/LPS/anti-GBM Ab 39 ± 8 mg/24 h, P<0.05). The prevalence of glomerular capillary thrombi was also reduced significantly by these treatments; from 22 ± 5% to 4± 1% in the case of anti-TNF-α antibodies and 28±5% to 13±4% with anti-IL-1β antibodies. Similarly, the glomerular neutrophil infiltrate was also reduced by these treatments; from 42±3 to 25±1 in the case of anti-TNF-α and 47± 2 to 30± 1 with anti-IL-1α antibodies. In contrast, passive immunization against IL-1α had no effect on either albumin excretion (4±3, 83±22 and 77±24 mg/24 h), glomerular capillary thrombi (2±1; 19±5 and 16±3) or glomerular neutrophil infiltrate (22± 3; 47± 5 and 48± 5 from the three groups respectively). These results demonstrate that enhanced antibody mediated injury in the kidney is modulated by TNF-α and IL-14bT but not by IL-lα.Keywords
This publication has 39 references indexed in Scilit:
- Interleukin 1: the first interleukinImmunology Today, 1990
- Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivoEuropean Journal of Immunology, 1990
- Effects of cytokines on vascular endothelium: Their role in vascular and immune injuryKidney International, 1989
- Interleukin-1 induces natriuresis in conscious rats: Role of renal prostaglandinsKidney International, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Biology and pharmacology of recombinant human interleukin-1β-induced rat ear inflammationInflammation Research, 1987
- Stimulation of ACTH release by human interleukin-1β, but not by interleukin-1α, in conscious, freely-moving ratsBiochemical and Biophysical Research Communications, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Relation between Rat Slow Alpha2-globulin and Alpha2-macroglobulin of Other MammalsNature, 1968